MPM Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 31
Professionals
  • Investments
  • 367
  • Portfolio
  • 37
  • Exits
  • 226
Exits

MPM Capital General Information

Description

Founded in 1997, MPM Capital is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in the biotechnology, healthcare, and medical device sectors.

Contact Information

Website
www.mpmcapital.com
Formerly Known As
MPM Asset Management
Year Founded
1997
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • 450 Kendall Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

MPM Capital Investments (367)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Umoja Biopharma 15-Jun-2021 Early Stage VC 00000 Drug Discovery Pre-Clinical Trials 0000 00000 00.0
0000000 0000000000 31-Mar-2021 00000 00000 00000 Drug Delivery Pre-Clinical Trials 0000 00000
00000 00000000 18-Mar-2021 00000 00000 0000 Drug Delivery Startup 0000 00000
0000000000 15-Mar-2021 00000 00000 00000 Drug Discovery Generating Revenue 0000000 0000000 00
0000 000000000000 24-Feb-2021 00000 00000 0000 Biotechnology Product Development 0000000000 0000 00.0
00000000 000000000 24-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000 00000 00.0
00000000 00000000 17-Dec-2020 00000 00000 00000 Drug Discovery Pre-Clinical Trials 0000000 0000000 00
00000 000000000 18-Nov-2020 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000 00000 00.0
Turmeric Acquisition 01-Nov-2020 PIPE Special Purpose Acquisition Company (SPAC) Generating Revenue/Not Profitable
Trishula Therapeutics 26-Aug-2020 Early Stage VC Drug Discovery Clinical Trials - Phase 1 0000 00000 00.0
You’re viewing 10 of 367 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MPM Capital Exits (226)

Company Name Exit Date Exit Type Exit Size
Werewolf Therapeutics 30-Apr-2021 IPO 00000
000000 00000000000 24-Feb-2021 000 00 00000000
0000000 12-Feb-2021 000000 0000000000 0000
0000 000000000000 21-Jan-2021 000000 0000000000 00000
0000 000000000000 21-Jan-2021 000000 0000000000 00000
00000000 00000000 08-Jan-2021 000 00000
0000000 02-Oct-2020 000 0000
0000000 21-Sep-2020 0000000000
Dyne Therapeutics 17-Sep-2020 IPO 00000
Naked Biome 11-Sep-2020 Merger/Acquisition
You’re viewing 10 of 226 exits. Get the full list »

MPM Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore MPM Capital‘s full profile, request access.

Request a free trial

MPM Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

MPM Capital Team (90)

Name Title Deals Funds Boards Office
Kristen Laguerre Managing Director, Chief Financial Officer & Chief Operating Officer Cambridge, MA
Ansbert Gadicke MD Co-Founder & Managing Director 00 00 0 Cambridge, MA
Luke Evnin Ph.D Co-Founder & Managing Director 00 00 0 Brisbane, CA
Bard Geesaman Ph.D Managing Director 00 0 0 Cambridge, MA
David Stack Managing Director 0 0 0 Cambridge, MA
You’re viewing 5 of 90 team members. Get the full list »

MPM Capital Co-Investors (161)

Name With Exits Lead Partner Series Industry
Astellas Venture Management 6 0 Series chart Industry bar
F2 Ventures 0 0 0 Series chart Industry bar
Deerfield Management 0 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
You’re viewing 5 of 161 co-investors. Get the full list »